Skip to main content
Caplight Logo









Filterlex Medical

Filterlex Medical

Private
CaesareaHealthcare & Life Scienceshttps://filterlex.com/

Last Round

Early Funding

Dec 21, 2021

Total Funding Raised

$11.5M

Company Overview

Filterlex Medical is a medical device company that develops the CAPTIS, a full-body embolic protection device designed to reduce the risk of stroke and other complications during catheter-based structural heart procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

embolic protectiontranscatheter heart valve replacementTAVRinterventional cardiologymedical devicestroke preventioncardiovascular devicecatheter-based deviceembolic protection deviceEPDclinical trialscath lab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Filterlex Medical Comparables

Compare Filterlex Medical with similar companies based on industry and business-model similarity.

Filterlex Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transverse Medical
93%
Emblok
92%
Protembis GmbH
92%

Filterlex Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 21, 2021
Series A ExtensionNov 18, 2021
GrantSep 16, 2019
Series AJul 16, 2019
GrantMay 1, 2019
Accelerator
Jun 1, 2016

Key People

Founding team and executive leadership

Eyal Teichman

Co-Founder CTO

Founding Team

Filterlex Medical Investors

Notable investors and investment history

Filterlex Medical investors
InvestorRounds
Alon Medtech VenturesAccelerator
The Jon DeHaan FoundationGrant
European Innovation Council (EIC) AcceleratorEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Web traffic grew 2727% MoM (from 74 to 2.1K monthly visitors)

  • Nov 18, 2021

    Raised $6M in Series A Extension funding.

Filterlex Medical Filings

Explore SEC and related filing metadata, where available.

Filterlex Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Filterlex Medical's valuation, stock price, and market status.

Is Filterlex Medical a public or private company?

Filterlex Medical is a private company.

What is the current stock price of Filterlex Medical?

Filterlex Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Filterlex Medical worth (valuation)?

Valuation information for Filterlex Medical is not publicly available.

Can I buy Filterlex Medical stock?

Filterlex Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Filterlex Medical's last funding round?

Filterlex Medical's most recent funding round was Early Funding on December 21, 2021.

Who are the main investors in Filterlex Medical?

Key investors in Filterlex Medical include Alon Medtech Ventures, The Jon DeHaan Foundation, European Innovation Council (EIC) Accelerator.

Will Filterlex Medical IPO soon?

No public IPO plans have been announced for Filterlex Medical.

How can I track Filterlex Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Filterlex Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCaesarea
Employee Range6
Year Founded2016
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?